The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
782
December 30, 1988
View Complete Issue         Table of Contents 2019 
Terconazole For Candida Vaginitis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Terconazole For Candida Vaginitis
December 30, 1988 (Issue: 782)
Terconazole (Terazol - Ortho), an imidazole derivative, was recently marketed in the USA for treatment of vulvovaginal candidiasis. It is available both as a 0.4% vaginal cream (Terazol 7) and in 80-mg vaginal suppositories (Terazol...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Terconazole For Candida Vaginitis
Article code: 782b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.